% alzhub.org library filter
% Source: https://alzhub.org/research?author=Hansson+O
% 78 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{buddhaeberlein2022-35542991,
  author  = {Budd Haeberlein, S. and Aisen, P. S. and Barkhof, F. and Chalkias, S. and Chen, T. and Cohen, S. and Dent, G. and Hansson, O. and others},
  title   = {{Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.30},
  pmid    = {35542991},
  url     = {https://doi.org/10.14283/jpad.2022.30}
}

@article{cummings2025-39780249,
  author  = {Cummings, J. L. and Atri, A. and Feldman, H. H. and Hansson, O. and Sano, M. and Knop, F. K. and Johannsen, P. and León, T. and others},
  title   = {{evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2025},
  doi     = {10.1186/s13195-024-01666-7},
  pmid    = {39780249},
  url     = {https://doi.org/10.1186/s13195-024-01666-7}
}

@article{lu2025-41082199,
  author  = {Lu, M. and Kim, M. J. and Collins, E. C. and Shcherbinin, S. and Ellinwood, A. K. and Yokoi, Y. and Brooks, D. A. and Hansson, O. and others},
  title   = {{Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.3869},
  pmid    = {41082199},
  url     = {https://doi.org/10.1001/jamaneurol.2025.3869}
}

@article{coughlan2025-40029638,
  author  = {Coughlan, G. T. and Klinger, H. M. and Boyle, R. and Betthauser, T. J. and Binette, A. P. and Christenson, L. and Chadwick, T. and Hansson, O. and others},
  title   = {{Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis}},
  journal = {JAMA neurology},
  year    = {2025},
  doi     = {10.1001/jamaneurol.2025.0013},
  pmid    = {40029638},
  url     = {https://doi.org/10.1001/jamaneurol.2025.0013}
}

@article{mattsson2009-19622817,
  author  = {Mattsson, N. and Zetterberg, H. and Hansson, O. and Andreasen, N. and Parnetti, L. and Jonsson, M. and Herukka, S. K. and van der Flier, W. M. and others},
  title   = {{CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment}},
  journal = {JAMA},
  year    = {2009},
  doi     = {10.1001/jama.2009.1064},
  pmid    = {19622817},
  url     = {https://doi.org/10.1001/jama.2009.1064}
}

@article{sims2023-9857475c,
  author  = {Sims, JR. and Zimmer, J. A. and Evans, C. D. and Lu, M. and Ardayfio, P. and Sparks, J. and Wessels, A. M. and Shcherbinin, S. and Wang, H. and Monkul Nery, E. S. and Collins, E. C. and Solomon, P. and Salloway, S. and Apostolova, L. G. and Hansson, O. and Ritchie, C. and Brooks, D. A. and Mintun, M. and Skovronsky, D. M. and {TRAILBLAZER-ALZ 2 Investigators}},
  title   = {{Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial}},
  journal = {JAMA},
  year    = {2023},
  pmid    = {37459141}
}

@article{rabinovici2025-39776249,
  author  = {Rabinovici, G. D. and Knopman, D. S. and Arbizu, J. and Benzinger, T. L. S. and Donohoe, K. J. and Hansson, O. and Herscovitch, P. and Kuo, P. H. and Lingler, J. H. and Minoshima, S. and others},
  title   = {{Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.14338},
  pmid    = {39776249},
  url     = {https://doi.org/10.1002/alz.14338}
}

@article{janelidze2018-30054439,
  author  = {Janelidze, S. and Mattsson, N. and Stomrud, E. and Lindberg, O. and Palmqvist, S. and Zetterberg, H. and Blennow, K. and Hansson, O.},
  title   = {{CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease}},
  journal = {Neurology},
  year    = {2018},
  doi     = {10.1212/wnl.0000000000006082},
  pmid    = {30054439},
  url     = {https://doi.org/10.1212/wnl.0000000000006082}
}

@article{palmqvist2016-26936941,
  author  = {Palmqvist, S. and Mattsson, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography}},
  journal = {Brain : a journal of neurology},
  year    = {2016},
  doi     = {10.1093/brain/aww015},
  pmid    = {26936941},
  url     = {https://doi.org/10.1093/brain/aww015}
}

@article{pereira2021-34077494,
  author  = {Pereira, J. B. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and van Westen, D. and Dage, J. L. and Mattsson-Carlgren, N. and Hansson, O.},
  title   = {{Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects}},
  journal = {Brain : a journal of neurology},
  year    = {2021},
  doi     = {10.1093/brain/awab163},
  pmid    = {34077494},
  url     = {https://doi.org/10.1093/brain/awab163}
}

@article{collij2024-39277604,
  author  = {Collij, L. E. and Mastenbroek, S. E. and Mattsson-Carlgren, N. and Strandberg, O. and Smith, R. and Janelidze, S. and Palmqvist, S. and Ossenkoppele, R. and Hansson, O.},
  title   = {{Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer's disease}},
  journal = {Nature Communications},
  year    = {2024},
  doi     = {10.1038/s41467-024-52299-1},
  pmid    = {39277604},
  url     = {https://doi.org/10.1038/s41467-024-52299-1}
}

@article{janelidze2023-36987840,
  author  = {Janelidze, S. and Barthélemy, N. R. and He, Y. and Bateman, R. J. and Hansson, O.},
  title   = {{Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.0199},
  pmid    = {36987840},
  url     = {https://doi.org/10.1001/jamaneurol.2023.0199}
}

@article{cicognola2021-33773595,
  author  = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.},
  title   = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00804-9},
  pmid    = {33773595},
  url     = {https://doi.org/10.1186/s13195-021-00804-9}
}

@article{hansson2023-37202517,
  author  = {Hansson, O. and Blennow, K. and Zetterberg, H. and Dage, J.},
  title   = {{Blood biomarkers for Alzheimer's disease in clinical practice and trials}},
  journal = {Nature aging},
  year    = {2023},
  doi     = {10.1038/s43587-023-00403-3},
  pmid    = {37202517},
  url     = {https://doi.org/10.1038/s43587-023-00403-3}
}

@article{hansson2018-29499171,
  author  = {Hansson, O. and Seibyl, J. and Stomrud, E. and Zetterberg, H. and Trojanowski, J. Q. and Bittner, T. and Lifke, V. and Corradini, V. and others},
  title   = {{CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2018},
  doi     = {10.1016/j.jalz.2018.01.010},
  pmid    = {29499171},
  url     = {https://doi.org/10.1016/j.jalz.2018.01.010}
}

@article{chouraki2015-25217292,
  author  = {Chouraki, V. and Beiser, A. and Younkin, L. and Preis, SR. and Weinstein, G. and Hansson, O. and Skoog, I. and Lambert, J. C. and others},
  title   = {{Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2015},
  doi     = {10.1016/j.jalz.2014.07.001},
  pmid    = {25217292},
  url     = {https://doi.org/10.1016/j.jalz.2014.07.001}
}

@article{mattsson2019-31314895,
  author  = {Mattsson, N. and Palmqvist, S. and Stomrud, E. and Vogel, J. and Hansson, O.},
  title   = {{Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2019.2214},
  pmid    = {31314895},
  url     = {https://doi.org/10.1001/jamaneurol.2019.2214}
}

@article{mattssoncarlgren2020-32398359,
  author  = {Mattsson-Carlgren, N. and Leuzy, A. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Strandberg, O. and Smith, R. and Hansson, O.},
  title   = {{The implications of different approaches to define AT(N) in Alzheimer disease}},
  journal = {Neurology},
  year    = {2020},
  doi     = {10.1212/wnl.0000000000009485},
  pmid    = {32398359},
  url     = {https://doi.org/10.1212/wnl.0000000000009485}
}

@article{gertje2023-36882326,
  author  = {Gertje, E. C. and Janelidze, S. and van Westen, D. and Cullen, N. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N.},
  title   = {{Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia}},
  journal = {Neurology},
  year    = {2023},
  doi     = {10.1212/wnl.0000000000207113},
  pmid    = {36882326},
  url     = {https://doi.org/10.1212/wnl.0000000000207113}
}

@article{ossenkoppele2019-30626656,
  author  = {Ossenkoppele, R. and Smith, R. and Ohlsson, T. and Strandberg, O. and Mattsson, N. and Insel, P. S. and Palmqvist, S. and Hansson, O.},
  title   = {{Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000006875},
  pmid    = {30626656},
  url     = {https://doi.org/10.1212/wnl.0000000000006875}
}

@article{mattsson2016-27534871,
  author  = {Mattsson, N. and Insel, P. S. and Palmqvist, S. and Portelius, E. and Zetterberg, H. and Weiner, M. and Blennow, K. and Hansson, O. and others},
  title   = {{Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2016},
  doi     = {10.15252/emmm.201606540},
  pmid    = {27534871},
  url     = {https://doi.org/10.15252/emmm.201606540}
}

@article{berron2020-32252068,
  author  = {Berron, D. and van Westen, D. and Ossenkoppele, R. and Strandberg, O. and Hansson, O.},
  title   = {{Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2020},
  doi     = {10.1093/brain/awaa068},
  pmid    = {32252068},
  url     = {https://doi.org/10.1093/brain/awaa068}
}

@article{garcia2024-38405341,
  author  = {Garcia, M. J. and Leadley, R. and Ross, J. and Bozeat, S. and Redhead, G. and Hansson, O. and Iwatsubo, T. and Villain, N. and others},
  title   = {{Prognostic and Predictive Factors in Early Alzheimer's Disease: A Systematic Review}},
  journal = {Journal of Alzheimer's disease reports},
  year    = {2024},
  doi     = {10.3233/adr-230045},
  pmid    = {38405341},
  url     = {https://doi.org/10.3233/adr-230045}
}

@article{tangen2022-36028328,
  author  = {Tangen, G. G. and Nilsson, M. H. and Stomrud, E. and Palmqvist, S. and Hansson, O.},
  title   = {{Spatial Navigation and Its Association With Biomarkers and Future Dementia in Memory Clinic Patients Without Dementia}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000201106},
  pmid    = {36028328},
  url     = {https://doi.org/10.1212/wnl.0000000000201106}
}

@article{cicognola2019-30547227,
  author  = {Cicognola, C. and Brinkmalm, G. and Wahlgren, J. and Portelius, E. and Gobom, J. and Cullen, N. C. and Hansson, O. and Parnetti, L. and others},
  title   = {{Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease}},
  journal = {Acta neuropathologica},
  year    = {2019},
  doi     = {10.1007/s00401-018-1948-2},
  pmid    = {30547227},
  url     = {https://doi.org/10.1007/s00401-018-1948-2}
}

@article{duits2014-24721526,
  author  = {Duits, F. H. and Teunissen, C. E. and Bouwman, F. H. and Visser, P. J. and Mattsson, N. and Zetterberg, H. and Blennow, K. and Hansson, O. and others},
  title   = {{The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean?}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2014},
  doi     = {10.1016/j.jalz.2013.12.023},
  pmid    = {24721526},
  url     = {https://doi.org/10.1016/j.jalz.2013.12.023}
}

@article{jansen2018-29188296,
  author  = {Jansen, W. J. and Ossenkoppele, R. and Tijms, B. M. and Fagan, A. M. and Hansson, O. and Klunk, W. E. and van der Flier, W. M. and Villemagne, V. L. and others},
  title   = {{Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia}},
  journal = {JAMA psychiatry},
  year    = {2018},
  doi     = {10.1001/jamapsychiatry.2017.3391},
  pmid    = {29188296},
  url     = {https://doi.org/10.1001/jamapsychiatry.2017.3391}
}

@article{cicognola2021-d7e9adeb,
  author  = {Cicognola, C. and Janelidze, S. and Hertze, J. and Zetterberg, H. and Blennow, K. and Mattsson-Carlgren, N. and Hansson, O.},
  title   = {{Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment}},
  journal = {Alzheimer's Research \& Therapy},
  year    = {2021},
  pmid    = {33773595}
}

@article{mattsson2012-22302554,
  author  = {Mattsson, N. and Rosén, E. and Hansson, O. and Andreasen, N. and Parnetti, L. and Jonsson, M. and Herukka, S. K. and van der Flier, W. M. and others},
  title   = {{Age and diagnostic performance of Alzheimer disease CSF biomarkers}},
  journal = {Neurology},
  year    = {2012},
  doi     = {10.1212/wnl.0b013e3182477eed},
  pmid    = {22302554},
  url     = {https://doi.org/10.1212/wnl.0b013e3182477eed}
}

@article{ossenkoppele2022-35643092,
  author  = {Ossenkoppele, R. and van der Kant, R. and Hansson, O.},
  title   = {{Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials}},
  journal = {The Lancet. Neurology},
  year    = {2022},
  doi     = {10.1016/s1474-4422(22)00168-5},
  pmid    = {35643092},
  url     = {https://doi.org/10.1016/s1474-4422(22)00168-5}
}

@article{zetterberg2008-18695061,
  author  = {Zetterberg, H. and Andreasson, U. and Hansson, O. and Wu, G. and Sankaranarayanan, S. and Andersson, M. E. and Buchhave, P. and Londos, E. and others},
  title   = {{Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease}},
  journal = {Archives of neurology},
  year    = {2008},
  doi     = {10.1001/archneur.65.8.1102},
  pmid    = {18695061},
  url     = {https://doi.org/10.1001/archneur.65.8.1102}
}

@article{tideman2022-35022305,
  author  = {Tideman, P. and Stomrud, E. and Leuzy, A. and Mattsson-Carlgren, N. and Palmqvist, S. and Hansson, O. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000013299},
  pmid    = {35022305},
  url     = {https://doi.org/10.1212/wnl.0000000000013299}
}

@article{hansson2006-16488378,
  author  = {Hansson, O. and Zetterberg, H. and Buchhave, P. and Londos, E. and Blennow, K. and Minthon, L.},
  title   = {{Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study}},
  journal = {The Lancet. Neurology},
  year    = {2006},
  doi     = {10.1016/s1474-4422(06)70355-6},
  pmid    = {16488378},
  url     = {https://doi.org/10.1016/s1474-4422(06)70355-6}
}

@article{grothe2018-30016411,
  author  = {Grothe, M. J. and Sepulcre, J. and Gonzalez-Escamilla, G. and Jelistratova, I. and Schöll, M. and Hansson, O. and Teipel, S. J. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Molecular properties underlying regional vulnerability to Alzheimer's disease pathology}},
  journal = {Brain : a journal of neurology},
  year    = {2018},
  doi     = {10.1093/brain/awy189},
  pmid    = {30016411},
  url     = {https://doi.org/10.1093/brain/awy189}
}

@article{janelidze2016-26783546,
  author  = {Janelidze, S. and Hertze, J. and Zetterberg, H. and Landqvist Waldö, M. and Santillo, A. and Blennow, K. and Hansson, O.},
  title   = {{Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease}},
  journal = {Annals of clinical and translational neurology},
  year    = {2016},
  doi     = {10.1002/acn3.266},
  pmid    = {26783546},
  url     = {https://doi.org/10.1002/acn3.266}
}

@article{westin2012-22303443,
  author  = {Westin, K. and Buchhave, P. and Nielsen, H. and Minthon, L. and Janciauskiene, S. and Hansson, O.},
  title   = {{CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease}},
  journal = {PloS one},
  year    = {2012},
  doi     = {10.1371/journal.pone.0030525},
  pmid    = {22303443},
  url     = {https://doi.org/10.1371/journal.pone.0030525}
}

@article{hansson2019-31010420,
  author  = {Hansson, O. and Lehmann, S. and Otto, M. and Zetterberg, H. and Lewczuk, P.},
  title   = {{Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2019},
  doi     = {10.1186/s13195-019-0485-0},
  pmid    = {31010420},
  url     = {https://doi.org/10.1186/s13195-019-0485-0}
}

@article{gertje2021-33046608,
  author  = {Gertje, E. C. and van Westen, D. and Panizo, C. and Mattsson-Carlgren, N. and Hansson, O.},
  title   = {{Association of Enlarged Perivascular Spaces and Measures of Small Vessel and Alzheimer Disease}},
  journal = {Neurology},
  year    = {2021},
  doi     = {10.1212/wnl.0000000000011046},
  pmid    = {33046608},
  url     = {https://doi.org/10.1212/wnl.0000000000011046}
}

@article{rosen2013-23800368,
  author  = {Rosén, C. and Hansson, O. and Blennow, K. and Zetterberg, H.},
  title   = {{Fluid biomarkers in Alzheimer's disease - current concepts}},
  journal = {Molecular neurodegeneration},
  year    = {2013},
  doi     = {10.1186/1750-1326-8-20},
  pmid    = {23800368},
  url     = {https://doi.org/10.1186/1750-1326-8-20}
}

@article{buchhave2012-22213792,
  author  = {Buchhave, P. and Minthon, L. and Zetterberg, H. and Wallin, A. K. and Blennow, K. and Hansson, O.},
  title   = {{Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia}},
  journal = {Archives of general psychiatry},
  year    = {2012},
  doi     = {10.1001/archgenpsychiatry.2011.155},
  pmid    = {22213792},
  url     = {https://doi.org/10.1001/archgenpsychiatry.2011.155}
}

@article{zettergren2019-30792413,
  author  = {Zettergren, A. and Höglund, K. and Kern, S. and Thorvaldsson, V. and Johan Skoog, M. and Hansson, O. and Andreasen, N. and Bogdanovic, N. and others},
  title   = {{Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein}},
  journal = {Scientific reports},
  year    = {2019},
  doi     = {10.1038/s41598-018-36650-3},
  pmid    = {30792413},
  url     = {https://doi.org/10.1038/s41598-018-36650-3}
}

@article{wallin2010-20458070,
  author  = {Wallin, A. K. and Blennow, K. and Zetterberg, H. and Londos, E. and Minthon, L. and Hansson, O.},
  title   = {{CSF biomarkers predict a more malignant outcome in Alzheimer disease}},
  journal = {Neurology},
  year    = {2010},
  doi     = {10.1212/wnl.0b013e3181dd4dd8},
  pmid    = {20458070},
  url     = {https://doi.org/10.1212/wnl.0b013e3181dd4dd8}
}

@article{groot2022-35649647,
  author  = {Groot, C. and Villeneuve, S. and Smith, R. and Hansson, O. and Ossenkoppele, R.},
  title   = {{Tau PET Imaging in Neurodegenerative Disorders}},
  journal = {Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year    = {2022},
  doi     = {10.2967/jnumed.121.263196},
  pmid    = {35649647},
  url     = {https://doi.org/10.2967/jnumed.121.263196}
}

@article{cullen2022-34937781,
  author  = {Cullen, N. and Janelidze, S. and Palmqvist, S. and Stomrud, E. and Mattsson-Carlgren, N. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative}},
  title   = {{Association of CSF Aβ38 Levels With Risk of Alzheimer Disease-Related Decline}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000013228},
  pmid    = {34937781},
  url     = {https://doi.org/10.1212/wnl.0000000000013228}
}

@article{benedet2022-35130933,
  author  = {Benedet, A. L. and Brum, W. S. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative} and Karikari, T. K. and Zimmer, E. R. and Zetterberg, H. and Blennow, K. and others},
  title   = {{The accuracy and robustness of plasma biomarker models for amyloid PET positivity}},
  journal = {Alzheimer's research \& therapy},
  year    = {2022},
  doi     = {10.1186/s13195-021-00942-0},
  pmid    = {35130933},
  url     = {https://doi.org/10.1186/s13195-021-00942-0}
}

@article{franzmeier2020-31953405,
  author  = {Franzmeier, N. and Neitzel, J. and Rubinski, A. and Smith, R. and Strandberg, O. and Ossenkoppele, R. and Hansson, O. and Ewers, M. and others},
  title   = {{Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2020},
  doi     = {10.1038/s41467-019-14159-1},
  pmid    = {31953405},
  url     = {https://doi.org/10.1038/s41467-019-14159-1}
}

@article{bali2024-38331843,
  author  = {Bali, D. and Hansson, O. and Janelidze, S.},
  title   = {{Effects of certain pre-analytical factors on the performance of plasma phospho-tau217}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01391-1},
  pmid    = {38331843},
  url     = {https://doi.org/10.1186/s13195-024-01391-1}
}

@article{collins2026-42565262,
  author  = {Collins, E. C. and Lu, M. and Beck, R. and Hendrix, J. and Hodsdon, M. E. and Hansson, O.},
  title   = {{Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease}},
  journal = {Alzheimer's \& Dementia},
  year    = {2026},
  doi     = {10.1002/alz.71740},
  pmid    = {42565262},
  url     = {https://doi.org/10.1002/alz.71740}
}

@article{stomrud2010-20142530,
  author  = {Stomrud, E. and Hansson, O. and Zetterberg, H. and Blennow, K. and Minthon, L. and Londos, E.},
  title   = {{Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults}},
  journal = {Archives of neurology},
  year    = {2010},
  doi     = {10.1001/archneurol.2009.316},
  pmid    = {20142530},
  url     = {https://doi.org/10.1001/archneurol.2009.316}
}

@article{henjum2016-27121148,
  author  = {Henjum, K. and Almdahl, I. S. and Årskog, V. and Minthon, L. and Hansson, O. and Fladby, T. and Nilsson, L. N.},
  title   = {{Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0182-1},
  pmid    = {27121148},
  url     = {https://doi.org/10.1186/s13195-016-0182-1}
}

@article{vogel2020-32457389,
  author  = {Vogel, J. W. and Iturria-Medina, Y. and Strandberg, O. T. and Smith, R. and Levitis, E. and Evans, A. C. and Hansson, O. and {Alzheimer’s Disease Neuroimaging Initiative} and others},
  title   = {{Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease}},
  journal = {Nature communications},
  year    = {2020},
  doi     = {10.1038/s41467-020-15701-2},
  pmid    = {32457389},
  url     = {https://doi.org/10.1038/s41467-020-15701-2}
}

@article{spotorno2020-32330946,
  author  = {Spotorno, N. and Acosta-Cabronero, J. and Stomrud, E. and Lampinen, B. and Strandberg, O. T. and van Westen, D. and Hansson, O.},
  title   = {{Relationship between cortical iron and tau aggregation in Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2020},
  doi     = {10.1093/brain/awaa089},
  pmid    = {32330946},
  url     = {https://doi.org/10.1093/brain/awaa089}
}

@article{smith2019-30508025,
  author  = {Smith, R. and Wibom, M. and Pawlik, D. and Englund, E. and Hansson, O.},
  title   = {{Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology}},
  journal = {JAMA neurology},
  year    = {2019},
  doi     = {10.1001/jamaneurol.2018.3692},
  pmid    = {30508025},
  url     = {https://doi.org/10.1001/jamaneurol.2018.3692}
}

@article{lindqvist2013-23911592,
  author  = {Lindqvist, D. and Hall, S. and Surova, Y. and Nielsen, H. M. and Janelidze, S. and Brundin, L. and Hansson, O.},
  title   = {{Cerebrospinal fluid inflammatory markers in Parkinson's disease--associations with depression, fatigue, and cognitive impairment}},
  journal = {Brain, behavior, and immunity},
  year    = {2013},
  doi     = {10.1016/j.bbi.2013.07.007},
  pmid    = {23911592},
  url     = {https://doi.org/10.1016/j.bbi.2013.07.007}
}

@article{yu2023-37031430,
  author  = {Yu, L. and Boyle, P. A. and Janelidze, S. and Petyuk, V. A. and Wang, T. and Bennett, D. A. and Hansson, O. and Schneider, J. A.},
  title   = {{Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults}},
  journal = {Acta neuropathologica},
  year    = {2023},
  doi     = {10.1007/s00401-023-02570-4},
  pmid    = {37031430},
  url     = {https://doi.org/10.1007/s00401-023-02570-4}
}

@article{demeyer2010-20697045,
  author  = {De Meyer, G. and Shapiro, F. and Vanderstichele, H. and Vanmechelen, E. and Engelborghs, S. and De Deyn, P. P. and Coart, E. and Hansson, O. and others},
  title   = {{Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people}},
  journal = {Archives of neurology},
  year    = {2010},
  doi     = {10.1001/archneurol.2010.179},
  pmid    = {20697045},
  url     = {https://doi.org/10.1001/archneurol.2010.179}
}

@article{vilacastelar2023-37279390,
  author  = {Vila-Castelar, C. and Chen, Y. and Langella, S. and Lopera, F. and Zetterberg, H. and Hansson, O. and Dage, J. L. and Janelidzde, S. and others},
  title   = {{Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.13314},
  pmid    = {37279390},
  url     = {https://doi.org/10.1002/alz.13314}
}

@article{hall2018-30185816,
  author  = {Hall, S. and Janelidze, S. and Surova, Y. and Widner, H. and Zetterberg, H. and Hansson, O.},
  title   = {{Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders}},
  journal = {Scientific reports},
  year    = {2018},
  doi     = {10.1038/s41598-018-31517-z},
  pmid    = {30185816},
  url     = {https://doi.org/10.1038/s41598-018-31517-z}
}

@article{wennstrom2015-26270969,
  author  = {Wennström, M. and Surova, Y. and Hall, S. and Nilsson, C. and Minthon, L. and Hansson, O. and Nielsen, H. M.},
  title   = {{The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies}},
  journal = {PloS one},
  year    = {2015},
  doi     = {10.1371/journal.pone.0135458},
  pmid    = {26270969},
  url     = {https://doi.org/10.1371/journal.pone.0135458}
}

@article{kumar2022-35641311,
  author  = {Kumar, A. and Janelidze, S. and Stomrud, E. and Palmqvist, S. and Hansson, O. and Mattsson-Carlgren, N. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{β-Amyloid-Dependent and -Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease}},
  journal = {Neurology},
  year    = {2022},
  doi     = {10.1212/wnl.0000000000200605},
  pmid    = {35641311},
  url     = {https://doi.org/10.1212/wnl.0000000000200605}
}

@article{bjorkqvist2012-22279551,
  author  = {Björkqvist, M. and Ohlsson, M. and Minthon, L. and Hansson, O.},
  title   = {{Evaluation of a previously suggested plasma biomarker panel to identify Alzheimer's disease}},
  journal = {PloS one},
  year    = {2012},
  doi     = {10.1371/journal.pone.0029868},
  pmid    = {22279551},
  url     = {https://doi.org/10.1371/journal.pone.0029868}
}

@article{jack2024-38934362,
  author  = {Jack, C. R. and Andrews, J. S. and Beach, T. G. and Buracchio, T. and Dunn, B. and Graf, A. and Hansson, O. and Ho, C. and others},
  title   = {{Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2024},
  doi     = {10.1002/alz.13859},
  pmid    = {38934362},
  url     = {https://doi.org/10.1002/alz.13859}
}

@article{provost2021-33398408,
  author  = {Provost, K. and Iaccarino, L. and Soleimani-Meigooni, D. N. and Baker, S. and Edwards, L. and Eichenlaub, U. and Hansson, O. and Jagust, W. and others},
  title   = {{Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts}},
  journal = {European journal of nuclear medicine and molecular imaging},
  year    = {2021},
  doi     = {10.1007/s00259-020-05152-8},
  pmid    = {33398408},
  url     = {https://doi.org/10.1007/s00259-020-05152-8}
}

@article{ohrfelt2016-27716408,
  author  = {Öhrfelt, A. and Brinkmalm, A. and Dumurgier, J. and Brinkmalm, G. and Hansson, O. and Zetterberg, H. and Bouaziz-Amar, E. and Hugon, J. and others},
  title   = {{The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2016},
  doi     = {10.1186/s13195-016-0208-8},
  pmid    = {27716408},
  url     = {https://doi.org/10.1186/s13195-016-0208-8}
}

@article{verberk2022-34845818,
  author  = {Verberk, I. M. W. and Misdorp, E. O. and Koelewijn, J. and Ball, A. J. and Blennow, K. and Dage, J. L. and Fandos, N. and Hansson, O. and others},
  title   = {{Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2022},
  doi     = {10.1002/alz.12510},
  pmid    = {34845818},
  url     = {https://doi.org/10.1002/alz.12510}
}

@article{hertze2010-21504133,
  author  = {Hertze, J. and Minthon, L. and Zetterberg, H. and Vanmechelen, E. and Blennow, K. and Hansson, O.},
  title   = {{Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2010},
  doi     = {10.3233/jad-2010-100207},
  pmid    = {21504133},
  url     = {https://doi.org/10.3233/jad-2010-100207}
}

@article{frisoni2025-40997838,
  author  = {Frisoni, G. B. and Hansson, O. and Nichols, E. and Garibotto, V. and Schindler, S. E. and van der Flier, W. M. and Jessen, F. and Villain, N. and others},
  title   = {{New landscape of the diagnosis of Alzheimer's disease}},
  journal = {Lancet (London, England)},
  year    = {2025},
  doi     = {10.1016/s0140-6736(25)01294-2},
  pmid    = {40997838},
  url     = {https://doi.org/10.1016/s0140-6736(25)01294-2}
}

@article{wennstrom2022-34991721,
  author  = {Wennström, M. and Janelidze, S. and Nilsson, K. P. R. and Bank, Netherlands Brain and Serrano, G. E. and Beach, T. G. and Dage, J. L. and Hansson, O.},
  title   = {{Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels}},
  journal = {Acta neuropathologica communications},
  year    = {2022},
  doi     = {10.1186/s40478-021-01307-2},
  pmid    = {34991721},
  url     = {https://doi.org/10.1186/s40478-021-01307-2}
}

@article{teunissen2022-34838239,
  author  = {Teunissen, C. E. and Verberk, I. M. W. and Thijssen, E. H. and Vermunt, L. and Hansson, O. and Zetterberg, H. and van der Flier, W. M. and Mielke, M. M. and others},
  title   = {{Blood-based biomarkers for Alzheimer's disease: towards clinical implementation}},
  journal = {The Lancet. Neurology},
  year    = {2022},
  doi     = {10.1016/s1474-4422(21)00361-6},
  pmid    = {34838239},
  url     = {https://doi.org/10.1016/s1474-4422(21)00361-6}
}

@article{leuzy2022-34859598,
  author  = {Leuzy, A. and Mattsson-Carlgren, N. and Palmqvist, S. and Janelidze, S. and Dage, J. L. and Hansson, O.},
  title   = {{Blood-based biomarkers for Alzheimer's disease}},
  journal = {EMBO molecular medicine},
  year    = {2022},
  doi     = {10.15252/emmm.202114408},
  pmid    = {34859598},
  url     = {https://doi.org/10.15252/emmm.202114408}
}

@article{smith2016-27357347,
  author  = {Smith, R. and Puschmann, A. and Schöll, M. and Ohlsson, T. and van Swieten, J. and Honer, M. and Englund, E. and Hansson, O.},
  title   = {{18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers}},
  journal = {Brain : a journal of neurology},
  year    = {2016},
  doi     = {10.1093/brain/aww163},
  pmid    = {27357347},
  url     = {https://doi.org/10.1093/brain/aww163}
}

@article{hansson2010-18486992,
  author  = {Hansson, O. and Zetterberg, H. and Vanmechelen, E. and Vanderstichele, H. and Andreasson, U. and Londos, E. and Wallin, A. and Minthon, L. and others},
  title   = {{Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment}},
  journal = {Neurobiology of aging},
  year    = {2010},
  doi     = {10.1016/j.neurobiolaging.2008.03.027},
  pmid    = {18486992},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2008.03.027}
}

@article{leuzy2021-33470669,
  author  = {Leuzy, A. and Cullen, N. C. and Mattsson-Carlgren, N. and Hansson, O.},
  title   = {{Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease}},
  journal = {Current opinion in neurology},
  year    = {2021},
  doi     = {10.1097/wco.0000000000000904},
  pmid    = {33470669},
  url     = {https://doi.org/10.1097/wco.0000000000000904}
}

@article{pereira2017-28692877,
  author  = {Pereira, J. B. and Westman, E. and Hansson, O. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease}},
  journal = {Neurobiology of aging},
  year    = {2017},
  doi     = {10.1016/j.neurobiolaging.2017.06.002},
  pmid    = {28692877},
  url     = {https://doi.org/10.1016/j.neurobiolaging.2017.06.002}
}

@article{brunnstrom2013-22911491,
  author  = {Brunnström, H. and Hansson, O. and Zetterberg, H. and Londos, E. and Englund, E.},
  title   = {{Correlations of CSF tau and amyloid levels with Alzheimer pathology in neuropathologically verified dementia with Lewy bodies}},
  journal = {International journal of geriatric psychiatry},
  year    = {2013},
  doi     = {10.1002/gps.3881},
  pmid    = {22911491},
  url     = {https://doi.org/10.1002/gps.3881}
}

@article{blennow2015-25840462,
  author  = {Blennow, K. and Mattsson, N. and Schöll, M. and Hansson, O. and Zetterberg, H.},
  title   = {{Amyloid biomarkers in Alzheimer's disease}},
  journal = {Trends in pharmacological sciences},
  year    = {2015},
  doi     = {10.1016/j.tips.2015.03.002},
  pmid    = {25840462},
  url     = {https://doi.org/10.1016/j.tips.2015.03.002}
}

@article{blennow2024-38818759,
  author  = {Blennow, K. and Hansson, O.},
  title   = {{[Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease]}},
  journal = {Lakartidningen},
  year    = {2024},
  pmid    = {38818759}
}

@article{harput2026-7b7b99fe,
  author  = {Harput, E. and Boccalini, C. and Scheffler, M. and Lovblad, K. and Ashton, N. J. and Zetterberg, H. and Hansson, O. and Lalive, H. M. and others},
  title   = {{Mapping Amyloid-PET Uptake in the White Matter in Alzheimer’s Disease}},
  journal = {Research Square},
  year    = {2026},
  doi     = {10.21203/rs.3.rs-10277565/v1},
  url     = {https://doi.org/10.21203/rs.3.rs-10277565/v1}
}